NDAINHALATIONGAS
Approved
Oct 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
XENON XE 133 (xenon xe-133) by Lantheus Medical Imaging is radiopharmaceutical activity [moa]. First approved in 1974.
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon XE-133 is an inhalation diagnostic radiopharmaceutical gas approved in 1974 for pulmonary ventilation imaging. It works by allowing patients to inhale the radioactive xenon gas, which distributes throughout the lungs and enables nuclear imaging to assess lung function and perfusion. This modality is primarily used in diagnostic settings to evaluate respiratory disorders and detect ventilation abnormalities.
LOE Approaching
As a legacy diagnostic product approaching loss of exclusivity with moderate competitive pressure (30%), this brand supports a small, specialized quality-focused team rather than large commercial expansion.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Inhalation Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xenon XE-133 offers a specialized career path focused on quality, compliance, and regulatory operations within a niche diagnostic radiopharmaceutical portfolio. This role suits professionals seeking depth in quality systems and international regulatory affairs rather than commercial-facing or high-growth environment opportunities.
International License Partner Quality Specialist
Worked on XENON XE 133 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.